Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1975 Apr;7(4):387–395. doi: 10.1128/aac.7.4.387

Effect of pH and Human Serum on the Susceptibility of Group D Streptococci (Enterococci) to Ampicillin In Vitro

D N Gilbert *, N Eubanks †
PMCID: PMC429150  PMID: 238465

Abstract

The in vitro susceptibility of group D streptococci (enterococci) to ampicillin was studied comparing the results obtained in Mueller-Hinton broth (MHB) with those obtained in normal human serum (NHS). The rate of enterococcal killing was consistently faster in NHS than in MHB at equivalent ampicillin concentrations. Whereas an increasing media pH appeared to decrease the susceptibility of enterococci to ampicillin by determinations of the minimum bactericidal concentration (MBC) of ampicillin, an opposite increase in susceptibility was observed when the rate of bactericidal activity was studied. This difference may be explainable by the instability of ampicillin at higher pH values. In both MHB and NHS a paradoxical decrease in the rate and extent of enterococcal killing occurred as the ampicillin concentration was increased above the minimally effective concentration. These results demonstrate the inadequacies of the MBC test system and the need for standardizing test media used for determining the susceptibility of enterococci to ampicillin.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaty H. N., Turck M., Petersdorf R. G. Activity of broad-spectrum antibiotics against enterococci and their efficacy in enterococcal endocarditis. Ann N Y Acad Sci. 1967 Sep 27;145(2):464–472. doi: 10.1111/j.1749-6632.1967.tb50246.x. [DOI] [PubMed] [Google Scholar]
  2. Beaty H. N., Turck M., Petersdorf R. G. Ampicillin in the treatment of enterococcal endocarditis. Ann Intern Med. 1966 Oct;65(4):701–707. doi: 10.7326/0003-4819-65-4-701. [DOI] [PubMed] [Google Scholar]
  3. Blumberg P. M., Strominger J. L. Isolation by covalent affinity chromatography of the penicillin-binding components from membranes of Bacillus subtilis. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3751–3755. doi: 10.1073/pnas.69.12.3751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bulger R. J., Nielson K. Effect of different media on in vitro studies of antibiotic combinations. Appl Microbiol. 1968 Jun;16(6):890–895. doi: 10.1128/am.16.6.890-895.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dowling H. F. Present status of therapy with combinations of antibiotics. Am J Med. 1965 Nov;39(5):796–811. doi: 10.1016/0002-9343(65)90098-7. [DOI] [PubMed] [Google Scholar]
  6. EAGLE H. The binding of penicillin in relation to its cytotoxic action. I. Correlation between the penicillin sensitivity and combining activity of intact bacteria and cell-free extracts. J Exp Med. 1954 Mar;99(3):207–226. doi: 10.1084/jem.99.3.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edwards J. R., Park J. T. Correlation between growth inhibition and the binding of various penicillins and cephalosporins to Staphylococcus aureus. J Bacteriol. 1969 Aug;99(2):459–462. doi: 10.1128/jb.99.2.459-462.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. GRAY I. R., TAI A. R., WALLACE J. G., CALDER J. H. ORAL TREATMENT OF BACTERIAL ENDOCARDITIS WITH PENICILLINS. Lancet. 1964 Jul 18;2(7351):110–114. doi: 10.1016/s0140-6736(64)90122-9. [DOI] [PubMed] [Google Scholar]
  9. Garrod L. P., Waterworth P. M. Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol. 1969 Sep;22(5):534–538. doi: 10.1136/jcp.22.5.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gilbert D. N., Kutscher E., Ireland P., Barnett J. A., Sanford J. P. Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S37–S45. doi: 10.1093/infdis/124.supplement_1.s37. [DOI] [PubMed] [Google Scholar]
  11. Greenwood D., O'Grady F. The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins. Br J Exp Pathol. 1972 Oct;53(5):457–464. [PMC free article] [PubMed] [Google Scholar]
  12. Hartmann R., Höltje J. V., Schwarz U. Targets of penicillin action in Escherichia coli. Nature. 1972 Feb 25;235(5339):426–429. doi: 10.1038/235426a0. [DOI] [PubMed] [Google Scholar]
  13. Hou J. P., Poole J. W. Kinetics and mechanism of degradation of ampicillin in solution. J Pharm Sci. 1969 Apr;58(4):447–454. doi: 10.1002/jps.2600580412. [DOI] [PubMed] [Google Scholar]
  14. Jusko W. J., Lewis G. P., Schmitt G. W. Ampicillin and hetacillin pharmacokinetics in normal and anephric subjects. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):90–99. doi: 10.1002/cpt197314190. [DOI] [PubMed] [Google Scholar]
  15. KLEIN J. O., FINLAND M. Ampicillin activity in vitro and absorption and excretion in normal young men. Am J Med Sci. 1963 May;245:544–555. [PubMed] [Google Scholar]
  16. Kunin C. M. Clinical significance of protein binding of the penicillins. Ann N Y Acad Sci. 1967 Sep 27;145(2):282–290. doi: 10.1111/j.1749-6632.1967.tb50225.x. [DOI] [PubMed] [Google Scholar]
  17. Leyh-Bouille M., Nakel M., Frère J. M., Johnson K., Ghuysen J. M., Nieto M., Perkins H. R. Penicillin-sensitive DD-carboxypeptidases from Streptomyces strains R39 and K11. Biochemistry. 1972 Mar 28;11(7):1290–1298. doi: 10.1021/bi00757a027. [DOI] [PubMed] [Google Scholar]
  18. Mandell G. L., Kaye D., Levison M. E., Hook E. W. Enterococcal endocarditis. An analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med. 1970 Feb;125(2):258–264. doi: 10.1001/archinte.125.2.258. [DOI] [PubMed] [Google Scholar]
  19. Medeiros A. A., O'Brien T. F., Wacker W. E., Yulug N. F. Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin. J Infect Dis. 1971 Dec;124 (Suppl):S59–S64. doi: 10.1093/infdis/124.supplement_1.s59. [DOI] [PubMed] [Google Scholar]
  20. RUTSTEIN D. D., INGENITO E. F., REYNOLDS W. E. The determination of albumin in human blood plasma and serum; a method based on the interaction of albumin with an anionic dye-2(4'-hydroxybenzeneazo) benzoic acid. J Clin Invest. 1954 Feb;33(2):211–221. doi: 10.1172/JCI102887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Simon H. J. Antimicrobial susceptibility of group D hemolytic streptococci (enterococci). Am J Med Sci. 1967 Jan;253(1):14–18. doi: 10.1097/00000441-196701000-00004. [DOI] [PubMed] [Google Scholar]
  22. Stewart G. T., Coles H. M., Nixon H. H., Holt R. J. "Penbritin": An Oral Penicillin with Broad-spectrum Activity. Br Med J. 1961 Jul 22;2(5246):200–206. doi: 10.1136/bmj.2.5246.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Strominger J. L. The actions of penicillin and other antibiotics on bacterial cell wall synthesis. Johns Hopkins Med J. 1973 Aug;133(2):63–81. [PubMed] [Google Scholar]
  24. Suginaka H., Blumberg P. M., Strominger J. L. Multiple penicillin-binding components in Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, and Escherichia coli. J Biol Chem. 1972 Sep 10;247(17):5279–5288. [PubMed] [Google Scholar]
  25. Toala P., McDonald A., Wilcox C., Finland M. Susceptibility of group D streptococcus (enterococcus) to 21 antibiotics in vitro, with special reference to species differences. Am J Med Sci. 1969 Dec;258(6):416–430. doi: 10.1097/00000441-196912000-00006. [DOI] [PubMed] [Google Scholar]
  26. Toala P., Wilcox C., Finland M. Effect of pH of medium and size of inoculum on activity of antibiotics against group D Streptococcus (Enterococcus). Appl Microbiol. 1970 Apr;19(4):629–637. doi: 10.1128/am.19.4.629-637.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zimelis V. M., Jackson G. G. Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism. J Infect Dis. 1973 Jun;127(6):663–669. doi: 10.1093/infdis/127.6.663. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES